Foodborne Botulinum Toxin Intoxication: Complete ICD-11 Coding Guide (1A11.0)
1. Introduction
Foodborne botulinum toxin poisoning represents one of the most serious and potentially fatal toxicological emergencies known to modern medicine. This condition results from the ingestion of food contaminated with the neurotoxin produced by the bacterium Clostridium botulinum, an anaerobic spore-forming microorganism capable of producing one of the most lethal substances known to science.
Botulinum toxin acts by blocking the release of acetylcholine at the neuromuscular junctions, resulting in characteristic descending flaccid paralysis that can compromise respiratory muscles and lead to acute respiratory failure. The severity of this poisoning requires immediate recognition and urgent medical intervention, as the prognosis depends directly on the speed of diagnosis and initiation of specific treatment.
From an epidemiological perspective, although it is considered a rare condition compared to other foodborne poisonings, foodborne botulism maintains significant relevance in public health due to its high mortality rate when not treated adequately and the potential for outbreaks associated with contaminated food that can affect multiple people simultaneously.
The correct coding of this condition in the ICD-11 system is absolutely critical for several reasons: it enables precise epidemiological tracking of cases and outbreaks, facilitates adequate allocation of resources for treatment including botulinum antitoxin, enables surveillance studies of food safety and quality, and ensures recognition of the severity of the condition for purposes of hospital management and health insurance. The differentiation between foodborne botulinum toxin poisoning and other forms of botulism is also essential for public health investigations and appropriate preventive measures.
2. Correct ICD-11 Code
Code: 1A11.0
Description: Food poisoning by botulinum toxin
Parent category: 1A11 - Botulism
This specific code was designated in the International Classification of Diseases, 11th Revision, to exclusively identify cases of botulism acquired through ingestion of food contaminated with preformed toxin from Clostridium botulinum. The hierarchical structure of ICD-11 positions this code within the broader category of botulism (1A11), but clearly differentiates it from other forms of disease presentation.
The specificity of this code is fundamental because the route of toxin acquisition has direct implications for both clinical management and public health measures. When we code a case as 1A11.0, we are indicating that there is an identified or suspected source food that may represent a risk to other individuals, triggering protocols for sanitary investigation and active case finding for additional cases.
Code 1A11.0 should be used as the principal diagnosis when food poisoning by botulinum toxin is the primary reason for the clinical encounter or hospital admission. In situations where complications develop, additional codes may be necessary to fully capture the clinical presentation, but 1A11.0 remains the fundamental code that identifies the etiology of the pathological process.
3. When to Use This Code
Code 1A11.0 should be applied in specific clinical scenarios where there is clear evidence or strong suspicion of botulinum toxin intoxication through the foodborne route. Below, we present detailed practical situations:
Scenario 1: Family outbreak after consumption of homemade preserves A family group presents to the emergency department with acute onset of neurological symptoms approximately 18 to 36 hours after consuming vegetable preserves prepared at home. Patients develop diplopia, ptosis, dysphagia, dry mouth, and progressive descending muscle weakness. The history reveals that the preserves were prepared without adequate sterilization techniques and stored at room temperature. This is a classic scenario for application of code 1A11.0, as all criteria are present: identified foodborne route, compatible clinical presentation, and common source of exposure.
Scenario 2: Isolated case after consumption of commercial canned food A previously healthy adult develops progressive neurological symptoms after consuming commercial canned product with a swollen can. The patient initially presents with mild gastrointestinal symptoms followed by characteristic neurological manifestations including blurred vision, difficulty swallowing, and symmetric muscle weakness. Laboratory investigation confirms the presence of botulinum toxin in the suspected food and in the patient's serum. This case should be coded as 1A11.0 even though it is isolated, because the route of acquisition is clearly foodborne.
Scenario 3: Patient with flaccid paralysis after consumption of unpasteurized honey Although intestinal botulism is more common in infants, adults with conditions that alter intestinal flora may develop colonization. However, when an adult develops symptoms after consuming honey or another food containing spores and there is evidence of preformed toxin in the food (not merely subsequent intestinal colonization), code 1A11.0 is appropriate. The critical distinction is the presence of preformed toxin in the food versus subsequent intestinal colonization.
Scenario 4: Intoxication after consumption of artisanally fermented foods Patient presents with typical neurological presentation of botulism after consuming fermented foods prepared artisanally, such as inadequately cured sausages or fermented fish. Detailed history reveals consumption of the suspected food 12 to 72 hours before symptom onset. Even without immediate laboratory confirmation, the combination of clear epidemiological history, characteristic clinical presentation, and absence of other explanations justifies the use of code 1A11.0 to initiate appropriate treatment and investigation.
Scenario 5: Laboratory-confirmed case with identified source food Patient admitted to intensive care unit with respiratory insufficiency secondary to neuromuscular paralysis. Investigation confirms the presence of botulinum toxin type A in the patient's serum and in the food consumed three days before symptom onset. There is photographic documentation of the food (homemade heart of palm preserve) and history of other family members with milder symptoms. This is the ideal scenario for coding 1A11.0, with all confirmatory elements present.
Scenario 6: Outbreak at social event with multiple cases Various participants at a social event develop symptoms compatible with botulism after consuming foods served at the event. Epidemiological investigation identifies a specific food (homemade pâté, sauce, or preserve) as the common source. Even if not all cases have individual laboratory confirmation, the presence of one confirmed case and clear epidemiological association justify the use of code 1A11.0 for all clinically compatible cases in the outbreak.
4. When NOT to Use This Code
Precise differentiation between foodborne botulinum toxin poisoning and other forms of botulism or similar conditions is essential for correct coding. Code 1A11.0 should NOT be used in the following situations:
Infant botulism from intestinal colonization: When infants develop botulism through intestinal colonization by Clostridium botulinum spores that germinate and produce toxin in vivo, rather than through ingestion of preformed toxin, this is not a case of classic foodborne poisoning. Although honey may be the source of the spores, the pathophysiological mechanism is different and requires alternative coding within category 1A11.
Wound botulism: Cases where Clostridium botulinum spores contaminate wounds and produce toxin locally, commonly associated with injectable drug use or contaminated traumatic injuries, should be coded with the appropriate code for wound botulism (1A11.1), not 1A11.0. The absence of a foodborne route is the critical differentiator.
Iatrogenic botulism: Rare complications related to therapeutic or cosmetic use of purified botulinum toxin (aesthetic procedures or medical treatments) should not be coded as foodborne poisoning. These cases require specific codes for procedure complications or adverse drug effects.
Similar neurological syndromes from other etiologies: Conditions such as Guillain-Barré syndrome, myasthenia gravis, organophosphate poisoning, or other neuropathies may present with similar neurological symptoms. Code 1A11.0 should only be used when there is clear evidence or strong suspicion of exposure to botulinum toxin via foodborne route. The presence of descending flaccid paralysis alone does not justify this code without appropriate epidemiological context.
Other bacterial foodborne poisonings: Poisonings from other preformed bacterial toxins in food (such as staphylococcal toxin or toxins from Bacillus cereus) have distinct clinical presentations and specific codes. The absence of neurological symptoms characteristic of botulism excludes the use of 1A11.0.
5. Step-by-Step Coding Process
Step 1: Assess Diagnostic Criteria
The first essential step is to confirm that the clinical presentation is compatible with botulinum toxin intoxication. The diagnostic criteria include:
Characteristic clinical manifestations: Presence of symmetric descending flaccid paralysis, typically initiating with bulbar symptoms (diplopia, ptosis, dysarthria, dysphagia), progressing to weakness of upper extremities and subsequently lower extremities. Autonomic symptoms such as dry mouth, constipation, urinary retention, and mydriasis are also common.
Compatible incubation period: Symptom onset between 12 and 72 hours after food exposure, although shorter periods (up to 6 hours) or longer periods (up to 10 days) are possible depending on the amount of toxin ingested.
Epidemiological history: Identification of consumption of high-risk foods, especially homemade preserves, canned foods with signs of deterioration, artisanally fermented products, or participation in an event with other cases.
Laboratory confirmation when available: Detection of botulinum toxin in serum, feces, or suspected food through mouse bioassay or molecular methods. It is important to note that the absence of laboratory confirmation does not exclude the diagnosis when the clinical and epidemiological presentation are strongly suggestive.
Step 2: Verify Specifiers
After confirming the diagnosis of foodborne botulinum toxin intoxication, it is important to document characteristics that may require additional coding:
Severity of presentation: Mild cases with isolated bulbar symptoms versus severe cases with respiratory insufficiency requiring mechanical ventilation. Although the base code is 1A11.0, severity should be documented for clinical management and may require additional codes for complications.
Complications developed: Aspiration pneumonia, respiratory insufficiency, cardiac arrhythmias, or other complications should be coded separately as secondary diagnoses, maintaining 1A11.0 as the principal code.
Type of toxin when identified: Although it does not change the principal code, identification of the type of botulinum toxin (A, B, E, F are the most common in humans) has epidemiological relevance and should be documented in the medical record.
Step 3: Differentiate from Other Codes
The main differentiation within the botulism category is:
1A11.0 versus 1A11.1: Code 1A11.1 encompasses other forms of botulism including wound botulism, intestinal botulism, and unspecified forms. The key difference is that 1A11.0 is exclusive for cases where preformed toxin was ingested through contaminated food. If there is any uncertainty about the route of acquisition, but botulism is confirmed, 1A11.1 may be more appropriate until further investigation clarifies the source.
Differentiation from similar neurological syndromes: Conditions such as Miller-Fisher syndrome (Guillain-Barré variant), acute myasthenia gravis, or organophosphate intoxication may mimic botulism. The key differentiator is the epidemiological history of food exposure and the specific pattern of descending paralysis with preserved sensation.
Step 4: Necessary Documentation
For appropriate coding of 1A11.0, the medical record must contain:
Checklist of mandatory information:
- Detailed description of neurological symptoms and their temporal progression
- Detailed food history from the 72 hours prior to symptom onset
- Specific identification of suspected foods (type, origin, preparation method, storage conditions)
- Complete neurological examination documenting pattern of muscle weakness
- Results of laboratory investigations when available
- Information about additional cases if applicable (outbreak)
- Notification to public health authorities
- Treatment instituted including administration of botulinum antitoxin
Adequate documentation: The documentation must be sufficiently detailed to justify the chosen code for subsequent audit, allow epidemiological tracking, and facilitate public health investigations. Photographs of the suspected food, when available, should be included in the medical record.
6. Complete Practical Example
Clinical Case
Initial presentation: A 42-year-old female patient, previously healthy, presents to the emergency department with the chief complaint of double vision and difficulty swallowing with 24 hours of symptom duration. She reports that two days prior, she attended a family dinner where she consumed various dishes, including homemade palm heart preserves prepared by a family member.
The morning after the dinner, she developed mild nausea and dry mouth sensation, symptoms she initially attributed to dehydration. However, the following day, she developed progressive blurred vision, difficulty focusing on objects, and sensation of "heavy eyelids". Throughout the day, she noticed increasing difficulty swallowing solid foods and subsequently liquids, in addition to "slurred" speech. She sought medical attention when family members noticed she was having difficulty keeping her eyes open and her speech was significantly impaired.
Evaluation performed: On physical examination, the patient is conscious and oriented, but presents with characteristic facies of bilateral ptosis, mydriatic pupils with sluggish photomotor reflex, and dry oral and ocular mucous membranes. Neurological examination reveals diplopia in all directions of gaze, moderate dysarthria, dysphagia to liquids, diminished gag reflex bilaterally, and mild proximal muscle weakness in upper extremities (strength grade 4/5). Lower extremities with preserved strength. Deep tendon reflexes globally hypoactive. Sensory examination completely preserved. Absence of fever. Vital signs stable, including oxygen saturation of 96% on room air.
Initial complementary investigation includes non-contrast head computed tomography with no abnormalities, normal serum electrolytes, and lumbar puncture with cerebrospinal fluid of normal characteristics. Electroneuromyography demonstrates incremental facilitation pattern on high-frequency repetitive stimulation, compatible with presynaptic neuromuscular junction disorder.
Detailed epidemiological investigation reveals that two other family members who consumed the same palm heart preserves developed mild gastrointestinal symptoms and blurred vision, but did not seek medical attention. The preserves were prepared artisanally by the patient's aunt, using fresh cooked palm heart and stored in glass jars with olive oil, without adequate pressure sterilization process. The jars were kept at room temperature for approximately three weeks before consumption.
Diagnostic reasoning: The combination of acute-onset bulbar neurological symptoms (diplopia, ptosis, dysarthria, dysphagia), absence of fever, preserved sensation, pattern of descending weakness, clear epidemiological history of consumption of inadequately prepared homemade preserves, and presence of other related cases establishes a highly probable clinical diagnosis of food poisoning from botulinum toxin.
Samples of the patient's serum, feces, and the suspected food (palm heart preserves) were collected and sent to a reference laboratory for detection of botulinum toxin. Public health authorities were notified immediately for outbreak investigation and active case finding for additional cases.
Justification for coding: Code 1A11.0 is fully justified in this case by the following elements: (1) clinical presentation characteristic of botulism with descending flaccid paralysis and prominent bulbar symptoms; (2) clearly foodborne route of acquisition with identification of high-risk food (homemade preserves); (3) compatible incubation period (approximately 36 hours); (4) presence of additional cases related to the same food source; (5) absence of alternative diagnoses that explain the clinical presentation.
Step-by-Step Coding
Analysis of criteria:
- ✓ Neurological manifestations compatible with botulism
- ✓ History of foodborne exposure to high-risk product
- ✓ Appropriate incubation period
- ✓ Exclusion of main differential diagnoses
- ✓ Electrophysiological pattern suggestive of presynaptic disorder
Code selected: 1A11.0 - Food poisoning from botulinum toxin
Complete justification: This code is most appropriate because it specifically identifies the foodborne route of acquisition of botulinum toxin, differentiating it from other forms of botulism. The presence of clearly identified source food (homemade palm heart preserves) and multiple related cases confirms the nature of food poisoning.
Complementary codes:
- Code for respiratory insufficiency if need for ventilatory support develops
- Code for aspiration pneumonia if complication occurs
- Z code for contact and exposure to communicable diseases for asymptomatic family members who consumed the same food
Treatment instituted: Patient was admitted to an intensive care unit for continuous respiratory monitoring. Botulinum antitoxin was administered after sample collection for laboratory confirmation. Nutritional support via nasogastric tube was initiated due to dysphagia. Prophylactic respiratory physiotherapy was implemented. Patient evolved with gradual improvement of symptoms over three weeks, discharged from hospital after recovery of swallowing capacity and adequate muscle strength.
7. Related Codes and Differentiation
Within the Same Category
1A11.1: Other forms of botulism
This category encompasses all forms of botulism that do not fit specifically as food poisoning from preformed toxin. The main differentiation between 1A11.0 and 1A11.1 lies in the mechanism of toxin acquisition.
When to use 1A11.1 versus 1A11.0:
Use 1A11.1 for wound botulism, where spores contaminate injured tissues and produce toxin locally. This type is particularly associated with injectable drug users with inadequate hygiene techniques. The absence of a history of food exposure and presence of an infected wound are the key differentiators.
Use 1A11.1 for intestinal botulism in adults, a rare form where spores germinate in the gastrointestinal tract and produce toxin in vivo, similar to what occurs in infants, but in adults with alterations in intestinal flora or gastrointestinal anatomy. It differs from 1A11.0 by the absence of preformed toxin in food.
Use 1A11.1 for cases of botulism where the route of acquisition remains undetermined after complete investigation, or for iatrogenic forms related to medical or cosmetic use of botulinum toxin.
Main difference: Code 1A11.0 is specific for cases where there is ingestion of preformed botulinum toxin in contaminated food, while 1A11.1 encompasses all other routes of acquisition and unspecified forms of botulism.
Differential Diagnoses
Guillain-Barré syndrome and variants: May present with flaccid paralysis, but typically is ascending (starts in lower limbs), has frequent sensory component, and presents with albuminocytologic dissociation in cerebrospinal fluid. The absence of initial bulbar symptoms and history of food exposure help differentiate.
Myasthenia gravis: May cause ptosis and diplopia, but generally has a more chronic course, diurnal fluctuation of symptoms, and responds to anticholinesterase testing. Absence of epidemiologic history of food exposure and presence of specific antibodies differentiate.
Organophosphate poisoning: May cause muscle weakness and autonomic symptoms, but presents with cholinergic syndrome with miosis (not mydriasis), muscle fasciculations, excessive sweating, and history of pesticide exposure. The presence of fasciculations clearly differentiates from botulism.
Brainstem stroke: May cause cranial nerve paralysis, but is generally asymmetric, has sudden onset, presents with imaging abnormalities, and does not have the characteristic progressive descending pattern of botulism.
8. Differences with ICD-10
In the International Classification of Diseases, 10th Revision, foodborne botulism was coded as A05.1 - Botulism. ICD-10 did not explicitly differentiate between food poisoning from botulinum toxin and other forms of botulism at the main code level, although it allowed for additional specifications.
Main changes in ICD-11:
ICD-11 introduces greater specificity by creating distinct codes within the botulism category. The code 1A11.0 specifically for foodborne poisoning allows clear differentiation from other forms (1A11.1), facilitating more precise epidemiological surveillance and recognition of foodborne outbreaks.
The hierarchical structure of ICD-11 is more logical and intuitive, with the parent category 1A11 encompassing all forms of botulism, but allowing immediate specification of the route of acquisition through subcodes. This organization facilitates both coding and data retrieval for epidemiological analyses.
Practical impact of these changes:
For healthcare professionals, increased specificity allows more precise documentation of the nature of exposure, facilitating communication with public health authorities and triggering appropriate food safety investigations.
For epidemiological surveillance systems, clear differentiation between foodborne and non-foodborne forms of botulism allows more effective tracking of food-related outbreaks and identification of trends in food safety.
For health managers and researchers, more granular data on specific types of botulism facilitate resource allocation, development of targeted prevention policies, and more robust epidemiological studies.
9. Frequently Asked Questions
How is the diagnosis of food poisoning by botulinum toxin made?
The diagnosis is primarily clinical, based on identification of the characteristic pattern of symmetric descending flaccid paralysis with prominent bulbar symptoms, associated with epidemiological history of consumption of at-risk foods. Laboratory confirmation through detection of botulinum toxin in serum, feces, or suspected food is definitive, but should not delay initiation of treatment. Mouse bioassay remains the gold standard for toxin detection, although molecular methods are increasingly available. Complementary tests such as electroneuromyography can demonstrate a pattern suggestive of presynaptic disorder, but are not specific.
Is treatment available in public health systems?
Botulinum antitoxin, the specific treatment for this condition, is generally available through public health programs in many countries, due to the severity of the disease and the need for rapid response to cases and outbreaks. The antitoxin is typically maintained in stock by central health authorities and made available upon notification of a suspected case. Treatment also includes intensive supportive care, including respiratory monitoring and ventilatory support when necessary, which are available in intensive care units of public hospitals. It is important that health professionals know the local protocols for rapid access to antitoxin in emergency situations.
How long does treatment and recovery take?
Acute treatment with botulinum antitoxin is administered as a single dose or according to specific protocol, generally within the first 24 to 72 hours after diagnosis. The antitoxin neutralizes circulating toxin, but does not reverse already established paralysis. Recovery depends on regeneration of new neuromuscular junctions, a process that occurs gradually over weeks to months. Mild cases may recover in two to three weeks, while severe cases may require months of rehabilitation. Patients requiring mechanical ventilation frequently remain hospitalized for several weeks. Physical therapy and rehabilitation are important components of prolonged treatment. Recovery is generally complete, but can be slow, and some patients experience residual fatigue and weakness for up to one year after poisoning.
Can this code be used in medical certificates and occupational documentation?
Yes, code 1A11.0 is appropriate for official medical documentation, including certificates, reports to employers, and documentation for disability benefit purposes. The severity of the condition justifies prolonged absence from professional activities during the period of acute treatment and recovery. It is important that medical documentation clearly describes the nature of the condition, treatment received, and functional limitations, as many employers and benefit systems may not be familiar with this rare condition. Accurate coding facilitates recognition of the severity of the condition by medical reviewers and administrative systems.
Which foods present the greatest risk of contamination with botulinum toxin?
Home-canned goods, especially low-acid vegetables (palm heart, asparagus, green beans, corn), represent the greatest risk due to inadequate sterilization techniques. Commercial canned products are rarely a source of contamination due to rigorous quality controls, but swollen, dented, or leaking cans should be discarded. Foods fermented artisanally, inadequately smoked or fermented fish, cured meat products without appropriate techniques, and honey (especially for infants) also present risk. Botulinum toxin does not necessarily alter the appearance, odor, or taste of foods, making prevention through appropriate preparation and preservation techniques essential.
Is it necessary to notify public health authorities about cases of botulism?
Yes, botulism is a notifiable disease in virtually all health systems worldwide due to its outbreak potential and the need for investigation of food sources. Immediate notification allows health authorities to initiate epidemiological investigation, identify other potential cases, locate and remove contaminated foods from circulation, and implement preventive measures. Health professionals have legal and ethical responsibility to notify suspected or confirmed cases to competent authorities. Notification also facilitates access to botulinum antitoxin maintained in strategic public health stockpiles.
Do people exposed to the same food but without symptoms need treatment?
People who consumed the same implicated food but remain asymptomatic should be carefully monitored for up to 10 days (maximum incubation period), but generally do not require prophylactic treatment with antitoxin due to risks associated with the treatment itself. Guidance should be provided on warning symptoms and the need to seek medical care immediately if symptoms develop. In some cases, gastric lavage or administration of activated charcoal may be considered if exposure was very recent, but efficacy is limited. The decision regarding prophylactic interventions should be individualized in consultation with infectious disease specialists and public health authorities.
Is there a vaccine against botulism available for the general population?
A vaccine against botulism exists, but is not available for the general population. It is reserved for groups at high occupational risk, such as researchers working with Clostridium botulinum in laboratories and military personnel in specific situations. Prevention for the general population is based on safe practices in food preparation, preservation, and consumption. This includes adequate sterilization of home-canned goods using appropriate pressure and temperature, proper refrigeration of foods, disposal of canned foods showing signs of deterioration, and education about risks associated with inadequate artisanal food preservation methods.
Conclusion: Accurate coding of food poisoning by botulinum toxin using ICD-11 code 1A11.0 is fundamental for epidemiological surveillance, appropriate clinical management, and public health response to this serious but treatable condition. Health professionals should maintain a high index of clinical suspicion, know the diagnostic criteria, and be familiar with notification protocols and access to specific treatment to optimize outcomes in affected patients.
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Food poisoning by botulinum toxin
- 🔬 PubMed Research on Food poisoning by botulinum toxin
- 🌍 WHO Health Topics
- 📋 CDC - Centers for Disease Control
- 📊 Clinical Evidence: Food poisoning by botulinum toxin
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-04